Squarepoint’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.9M | Buy |
321,138
+112,250
| +54% | +$3.41M | 0.01% | 997 |
|
|
2026
Q1 | $7.07M | Buy |
208,888
+87,125
| +72% | +$2.47M | 0.01% | 1280 |
|
|
2025
Q4 | $3.31M | Buy |
+121,763
| New | +$4.27M | ﹤0.01% | 1727 |
|
|
2025
Q2 | – | Sell |
-37,920
| Closed | -$1.11M | – | 4439 |
|
|
2025
Q1 | $1.11M | Sell |
37,920
-124,495
| -77% | -$4.13M | ﹤0.01% | 2569 |
|
|
2024
Q4 | $5.34M | Buy |
+162,415
| New | +$7.63M | 0.01% | 1576 |
|
|
2024
Q3 | – | Sell |
-6,622
| Closed | -$301K | – | 4058 |
|
|
2024
Q2 | $286K | Sell |
6,622
-105,444
| -94% | -$3.81M | ﹤0.01% | 3452 |
|
|
2024
Q1 | $3.28M | Buy |
112,066
+78,140
| +230% | +$2.09M | 0.01% | 1765 |
|
|
2023
Q4 | $756K | Buy |
33,926
+16,819
| +98% | +$377K | ﹤0.01% | 2722 |
|
|
2023
Q3 | $423K | Buy |
+17,107
| New | +$453K | ﹤0.01% | 2919 |
|
|
2023
Q2 | – | Sell |
-10,956
| Closed | -$252K | – | 3516 |
|
|
2023
Q1 | $252K | Sell |
10,956
-14,775
| -57% | -$392K | ﹤0.01% | 2672 |
|
|
2022
Q4 | $723K | Buy |
25,731
+8,563
| +50% | +$241K | ﹤0.01% | 2055 |
|
|
2022
Q3 | $486K | Sell |
17,168
-84,023
| -83% | -$2.25M | ﹤0.01% | 2215 |
|
|
2022
Q2 | $2.24M | Buy |
101,191
+66,819
| +194% | +$1.51M | 0.01% | 1118 |
|
|
2022
Q1 | $1M | Sell |
34,372
-8,257
| -19% | -$252K | ﹤0.01% | 1587 |
|
|
2021
Q4 | $1.4M | Buy |
+42,629
| New | +$1.72M | ﹤0.01% | 1480 |
|
|
2021
Q1 | – | Sell |
-103,454
| Closed | -$4.48M | – | 3049 |
|
|
2020
Q4 | $4.48M | Sell |
103,454
-27,952
| -21% | -$1.11M | 0.03% | 534 |
|
|
2020
Q3 | $4.6M | Buy |
+131,406
| New | +$5.76M | 0.06% | 368 |
|
|
2020
Q2 | – | Sell |
-24,630
| Closed | -$874K | – | 2191 |
|
|
2020
Q1 | $874K | Sell |
24,630
-87,635
| -78% | -$4.05M | 0.02% | 774 |
|
|
2019
Q4 | $5.36M | Buy |
+112,265
| New | +$4.24M | 0.03% | 484 |
|
|
2019
Q3 | – | Sell |
-17,477
| Closed | -$872K | – | 2306 |
|
|
2019
Q2 | $872K | Buy |
+17,477
| New | +$934K | 0.01% | 1338 |
|
|
2019
Q1 | – | Sell |
-5,782
| Closed | -$267K | – | 2112 |
|
|
2018
Q4 | $267K | Sell |
5,782
-24,652
| -81% | -$1.52M | ﹤0.01% | 1554 |
|
|
2018
Q3 | $2.35M | Buy |
30,434
+20,253
| +199% | +$1.63M | 0.03% | 664 |
|
|
2018
Q2 | $858K | Buy |
+10,181
| New | +$888K | 0.01% | 945 |
|
|
2018
Q1 | – | Sell |
-17,088
| Closed | -$977K | – | 1645 |
|
|
2017
Q4 | $977K | Buy |
17,088
+12,927
| +311% | +$813K | 0.02% | 840 |
|
|
2017
Q3 | $278K | Sell |
4,161
-1,000
| -19% | -$60.1K | 0.01% | 1213 |
|
|
2017
Q2 | $266K | Buy |
+5,161
| New | +$264K | 0.01% | 1188 |
|
Other funds holding AGIO
FCM
LCM
AC
EAM
NAMI
Squarepoint's AGIO Position: Q2 2026 in Review
Squarepoint increased its Agios Pharmaceuticals (AGIO) stake by 54% in Q2 2026, buying an estimated $3.41M and bringing the position to 321,138 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #997.
Squarepoint first reported a position in AGIO in Q2 2017 and has held it in 26 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- Squarepoint held 321,138 shares of Agios Pharmaceuticals worth $11.9M as of Q2 2026.
- Squarepoint bought 112,250 Agios Pharmaceuticals shares in Q2 2026, an estimated $3.41M.
- Agios Pharmaceuticals made up 0.01% of Squarepoint's portfolio in Q2 2026, its #997 holding.
- Squarepoint first reported a position in Agios Pharmaceuticals in Q2 2017 and has held it in 26 quarters since.
- 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.